Clinical Trials Browser

Phase 1/2 × Breast Neoplasms, Male × Vorinostat × Clear all

NCT00368875 2015-11-05

Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer

Phase 1/2 Completed

54 enrolled 9 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00258349 2014-06-02

Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer

Phase 1/2 Completed

16 enrolled 7 charts

Breast Neoplasms, Breast Neoplasms, Male